Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model

BACKGROUND: The Japanese ‘BALAD' model offers the first objective, biomarker-based, tool for assessment of prognosis in hepatocellular carcinoma, but relies on dichotomisation of the constituent data, has not been externally validated, and cannot be applied to the individual patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, R, Berhane, S, Teng, M, Cox, T, Tada, T, Toyoda, H, Kumada, T, Kagebayashi, C, Satomura, S, Johnson, P J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992496/
https://www.ncbi.nlm.nih.gov/pubmed/24691419
http://dx.doi.org/10.1038/bjc.2014.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992496/
https://www.ncbi.nlm.nih.gov/pubmed/24691419
http://dx.doi.org/10.1038/bjc.2014.130

Ejemplares similares